IOL CHEMICALS & PHARM. | ADVANCED ENZYME TECHNOLOGIES | IOL CHEMICALS & PHARM./ ADVANCED ENZYME TECHNOLOGIES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 31.0 | 44.1% | View Chart |
P/BV | x | 1.6 | 3.5 | 44.5% | View Chart |
Dividend Yield | % | 1.0 | 1.3 | 77.3% |
IOL CHEMICALS & PHARM. ADVANCED ENZYME TECHNOLOGIES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
ADVANCED ENZYME TECHNOLOGIES Mar-23 |
IOL CHEMICALS & PHARM./ ADVANCED ENZYME TECHNOLOGIES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 328 | 163.5% | |
Low | Rs | 272 | 225 | 121.0% | |
Sales per share (Unadj.) | Rs | 377.6 | 48.3 | 781.1% | |
Earnings per share (Unadj.) | Rs | 23.7 | 9.3 | 255.1% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 12.4 | 254.1% | |
Dividends per share (Unadj.) | Rs | 4.00 | 5.00 | 80.0% | |
Avg Dividend yield | % | 1.0 | 1.8 | 54.7% | |
Book value per share (Unadj.) | Rs | 256.8 | 110.5 | 232.5% | |
Shares outstanding (eoy) | m | 58.71 | 111.82 | 52.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 5.7 | 18.7% | |
Avg P/E ratio | x | 17.1 | 29.8 | 57.3% | |
P/CF ratio (eoy) | x | 12.8 | 22.3 | 57.5% | |
Price / Book Value ratio | x | 1.6 | 2.5 | 62.9% | |
Dividend payout | % | 16.9 | 53.8 | 31.4% | |
Avg Mkt Cap | Rs m | 23,743 | 30,939 | 76.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 1,148 | 146.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 5,406 | 410.1% | |
Other income | Rs m | 256 | 255 | 100.6% | |
Total revenues | Rs m | 22,427 | 5,661 | 396.2% | |
Gross profit | Rs m | 2,257 | 1,534 | 147.1% | |
Depreciation | Rs m | 462 | 350 | 131.8% | |
Interest | Rs m | 165 | 35 | 473.5% | |
Profit before tax | Rs m | 1,887 | 1,404 | 134.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 365 | 135.6% | |
Profit after tax | Rs m | 1,391 | 1,039 | 134.0% | |
Gross profit margin | % | 10.2 | 28.4 | 35.9% | |
Effective tax rate | % | 26.2 | 26.0 | 100.9% | |
Net profit margin | % | 6.3 | 19.2 | 32.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 7,221 | 133.9% | |
Current liabilities | Rs m | 5,025 | 776 | 647.9% | |
Net working cap to sales | % | 20.9 | 119.2 | 17.6% | |
Current ratio | x | 1.9 | 9.3 | 20.7% | |
Inventory Days | Days | 43 | 255 | 17.0% | |
Debtors Days | Days | 8 | 68 | 12.3% | |
Net fixed assets | Rs m | 11,017 | 6,884 | 160.0% | |
Share capital | Rs m | 587 | 224 | 262.5% | |
"Free" reserves | Rs m | 14,490 | 12,127 | 119.5% | |
Net worth | Rs m | 15,077 | 12,351 | 122.1% | |
Long term debt | Rs m | 0 | 78 | 0.0% | |
Total assets | Rs m | 20,684 | 14,105 | 146.6% | |
Interest coverage | x | 12.5 | 41.4 | 30.1% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.4 | 279.7% | |
Return on assets | % | 7.5 | 7.6 | 98.9% | |
Return on equity | % | 9.2 | 8.4 | 109.7% | |
Return on capital | % | 13.6 | 11.6 | 117.5% | |
Exports to sales | % | 26.7 | 17.3 | 154.2% | |
Imports to sales | % | 0 | 7.8 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 937 | 632.6% | |
Imports (cif) | Rs m | NA | 420 | 0.0% | |
Fx inflow | Rs m | 5,930 | 937 | 632.6% | |
Fx outflow | Rs m | 6,052 | 420 | 1,441.0% | |
Net fx | Rs m | -122 | 518 | -23.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 1,404 | 87.1% | |
From Investments | Rs m | -1,200 | -2,982 | 40.2% | |
From Financial Activity | Rs m | -41 | -258 | 15.9% | |
Net Cashflow | Rs m | -18 | -1,709 | 1.1% |
Indian Promoters | % | 48.2 | 2.4 | 1,991.3% | |
Foreign collaborators | % | 0.0 | 41.1 | - | |
Indian inst/Mut Fund | % | 1.7 | 30.6 | 5.6% | |
FIIs | % | 1.4 | 23.0 | 6.1% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 56.5 | 91.7% | |
Shareholders | 130,003 | 68,640 | 189.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | ADVANCED ENZYME TECHNOLOGIES | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.56% | -0.22% | 0.97% |
1-Month | 5.64% | 8.98% | 2.08% |
1-Year | -1.14% | 50.22% | 55.37% |
3-Year CAGR | -12.91% | 0.45% | 15.04% |
5-Year CAGR | 16.34% | 15.10% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the ADVANCED ENZYME TECHNOLOGIES share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of ADVANCED ENZYME TECHNOLOGIES the stake stands at 43.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of ADVANCED ENZYME TECHNOLOGIES.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
ADVANCED ENZYME TECHNOLOGIES paid Rs 5.0, and its dividend payout ratio stood at 53.8%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of ADVANCED ENZYME TECHNOLOGIES.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.